Efforts Increase To Boost Validity Of Meta-Analyses

Meta-analysis, which uses systematic methods to search, combine, and evaluate research literature, has been praised for making the review article more scientific and objective. But studies showing that journals are much more likely to publish the results of positive over negative clinical trials have led some to question the validity and objectivity of meta-analyses. Many in the medical community are concerned that this publication bias may skew the results of meta-analyses, which increasingly

Written byStephen Hoffert
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Meta-analysis, which uses systematic methods to search, combine, and evaluate research literature, has been praised for making the review article more scientific and objective. But studies showing that journals are much more likely to publish the results of positive over negative clinical trials have led some to question the validity and objectivity of meta-analyses. Many in the medical community are concerned that this publication bias may skew the results of meta-analyses, which increasingly are used by doctors in devising recommendations for patient treatment. In hopes of reducing this publication bias, some critics are pushing for a registry of unreported trials. But citing problems like the poor experimental design of many unpublished studies, other critics question if the registry can improve the validity of meta-analyses.

REGISTRY REJECTION: New England Journal of Medicine's Jerome Kassirer is concerned about the quality of unreviewed research. "The potential for publication bias concerns us because physicians ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies